These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38164615)

  • 21. Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[
    Mori W; Hatori A; Zhang Y; Kurihara Y; Yamasaki T; Xie L; Kumata K; Hu K; Fujinaga M; Zhang MR
    Bioorg Med Chem; 2019 Aug; 27(16):3568-3573. PubMed ID: 31278005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target occupancy study and whole-body dosimetry with a MAGL PET ligand [
    Arakawa R; Takano A; Nag S; Jia Z; Amini N; Maresca KP; Zhang L; Keliher EJ; Butler CR; Piro JR; Samad TA; Smith D; Nason D; O'Neil S; Trapa P; Fonseca KR; Litchfield J; McCarthy T; Carson RE; Halldin C
    EJNMMI Res; 2022 Mar; 12(1):13. PubMed ID: 35244788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
    Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
    Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a highly-specific
    Chen Z; Mori W; Rong J; Schafroth MA; Shao T; Van RS; Ogasawara D; Yamasaki T; Hiraishi A; Hatori A; Chen J; Zhang Y; Hu K; Fujinaga M; Sun J; Yu Q; Collier TL; Shao Y; Cravatt BF; Josephson L; Zhang MR; Liang SH
    Acta Pharm Sin B; 2021 Jun; 11(6):1686-1695. PubMed ID: 34221877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
    Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
    Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical Evaluation of
    Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
    J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors.
    Di Stefano M; Masoni S; Bononi G; Poli G; Galati S; Gado F; Manzi S; Vagaggini C; Brai A; Caligiuri I; Asif K; Rizzolio F; Macchia M; Chicca A; Sodi A; Di Bussolo V; Minutolo F; Meier P; Gertsch J; Granchi C; Dreassi E; Tuccinardi T
    Eur J Med Chem; 2024 Jan; 263():115916. PubMed ID: 37976705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Shao T; Chen Z; Rong J; Belov V; Chen J; Jeyarajan A; Deng X; Fu H; Yu Q; Rwema SH; Lin W; Papisov M; Josephson L; Chung RT; Liang SH
    Acta Pharm Sin B; 2022 Jan; 12(1):308-315. PubMed ID: 35127387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical characterization of [
    Koike T; Constantinescu CC; Ikeda S; Nishi T; Sunahara E; Miyamoto M; Cole P; Barret O; Alagille D; Papin C; Morley T; Fowles K; Seibyl J; Tamagnan G; Kuroita T
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1148-1156. PubMed ID: 34651220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of the monoacylglycerol lipase (MAGL) radiotracer [
    Mikkelsen JD; Aripaka SS; Egilmez CB; Pazarlar BA
    Neurochem Int; 2024 May; 175():105717. PubMed ID: 38447759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
    Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.
    Grimsey NL; Savinainen JR; Attili B; Ahamed M
    Drug Discov Today; 2020 Feb; 25(2):330-343. PubMed ID: 31622747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
    Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
    J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
    Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
    Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Analysis of
    Takano A; Chen L; Nag S; Brodney MA; Arakawa R; Chang C; Amini N; Doran SD; Dutra JK; McCarthy TJ; Nolan CE; O'Neill BT; Villalobos A; Zhang L; Halldin C
    J Nucl Med; 2019 Jul; 60(7):992-997. PubMed ID: 30530832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.